Saroja Pharma In, a company in the Specialty Chemicals industry, reported revenue of ₹18 crore and net profit of ₹0.53 crore for the September 2026 quarter.
Saroja Pharma In (NSE: SAROJA-SM) closed at ₹36.00 on 19 Nov 2026, down 14.3% over the past year. Its market capitalisation is ₹14 crore and it trades at 9.2 times earnings.
Incorporated in 2023, Saroja Pharma Ltd is mainly in the business of trading Thionyl Chloride chemical and pharmaceutical intermeddles, etc.
Descriptive research only, not investment advice. Evenstocks is not a SEBI-registered investment adviser.